EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Turkish translation, validity, and reliability of the European organization for research and treatment of cancer quality of life-high dose chemotherapy29 in patients undergone hematopoietic stem cell transplantation

Vesile Yildiz Kabak iD, Sevilay Karahan iD, Elifcan Aladağ Karakulak iD, Tülin Düger iD, Songül Atasavun Uysal iD, Fulya Ipek Erdem iD, Hakan Göker iD

Turkish Journal of Medical Sciences · 20.06.2025 · 55 (3) · 540-546

DOI: 10.55730/1300-0144.6001 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 20.06.2025. Verfasst von Vesile Yildiz Kabak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Physiotherapy and Rehabilitation, Faculty of Physical Therapy and Rehabilitation, Hacettepe University, Ankara, Turkiye. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Quality of Life, Neoplasms, Antineoplastic Agents. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aim: Our aim was to investigate psychometric properties of the Turkish version of the European organization for research and treatment of cancer quality of life-high dose chemotherapy29 (EORTC QLQ-HDC29) in patients treated with hematopoietic stem cell transplantation (HSCT). Materials and methods: Patients between the ages of 18 and 65 years and undergone HSCT were included. The European organization for research and treatment of cancer quality of life questionnaire–cancer30 the Eastern cooperative oncology group performance score, and the functional assessment of cancer therapy–bone marrow transplant were used to determine convergent validity. Reliability was assessed through the calculation of Cronbach’s alpha and intra-class correlation coefficient (ICC) values.

Results

Totally 151 patients were included. The convergent validity analysis between the EORTC QLQ-HDC29 and the other variables revealed significant, low to strong correlations (p ˂ 0.05). The test-retest reliability of the questionnaire was excellent (ICC values ranged from 0.886 to 1.000). The internal consistency values were acceptable except for the “Worries/Anxiety” and “Inpatient Issues” scales (ranged from 0.175 to 0.985).

Conclusion

The reliability and validity of Turkish version of the EORTC QLQ-HDC29 was feasible and acceptable in patients treatedwith HSCT. Further research is required to ascertain the psychometric properties of the EORTC QLQ-HD29.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationQuality of LifeNeoplasmsAntineoplastic AgentsHumansAdultFemaleMaleTurkeyMiddle AgedReproducibility of ResultsPsychometricsSurveys and QuestionnairesYoung AdultAdolescentTranslationsAged

Stichwörter der Autor:innen

Hematopoietic stem cell transplantationquality of lifereliabilityvalidity

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Basic Physiotherapy and Rehabilitation, Faculty of Physical Therapy and Rehabilitation, Hacettepe University, Ankara, Turkiye.
  • Division of Biostatistics, Department of Basic Sciences, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.
  • Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara Turkiye.
  • Faculty of Physical Therapy and Rehabilitation, Dokuz Eylül University, İzmir, Turkiye.

ORCID-Profile: Vesile Yildiz Kabak, Sevilay Karahan, Elifcan Aladağ Karakulak, Tülin Düger, Songül Atasavun Uysal, Fulya Ipek Erdem, Hakan Göker

Zitieren

APA

Yildiz Kabak, V., Karahan, S., Aladağ Karakulak, E., Düger, T., Atasavun Uysal, S., Ipek Erdem, F., & Göker, H. (2025). Turkish translation, validity, and reliability of the European organization for research and treatment of cancer quality of life-high dose chemotherapy29 in patients undergone hematopoietic stem cell transplantation. Turkish Journal of Medical Sciences, 55(3), 540-546. https://doi.org/10.55730/1300-0144.6001

Vancouver

Yildiz Kabak V, Karahan S, Aladağ Karakulak E, Düger T, Atasavun Uysal S, Ipek Erdem F, et al. Turkish translation, validity, and reliability of the European organization for research and treatment of cancer quality of life-high dose chemotherapy29 in patients undergone hematopoietic stem cell transplantation. Turkish Journal of Medical Sciences. 2025;55(3):540-546. doi:10.55730/1300-0144.6001

BibTeX
@article{YildizKabak2025,
  author = {Yildiz Kabak, Vesile and Karahan, Sevilay and Aladağ Karakulak, Elifcan and Düger, Tülin and Atasavun Uysal, Songül and Ipek Erdem, Fulya and Göker, Hakan},
  title = {Turkish translation, validity, and reliability of the European organization for research and treatment of cancer quality of life-high dose chemotherapy29 in patients undergone hematopoietic stem cell transplantation},
  journal = {Turkish Journal of Medical Sciences},
  year = {2025},
  volume = {55},
  number = {3},
  pages = {540--546},
  doi = {10.55730/1300-0144.6001}
}
Kostenlos starten →